Home » Topics » Conferences

Conferences
RSS

Roche and Genentech prepare prodrugs of fibrinogen antagonist

Sep. 6, 1996

No Comments

Thalidomide derivatives as leads for septic shock therapy

Sep. 6, 1996

No Comments

Arginine analogues for shock

Sep. 6, 1996

No Comments

CGS-28106 for hypertension and congestive heart failure

Sep. 6, 1996

No Comments

Zambon selects a dopaminergic compound for evaluation in cardiovascular/renal disorders

Sep. 6, 1996

No Comments

Orally active dual NK1/NK2 antagonist from Merck & Co.

Sep. 6, 1996

No Comments

New adenosine A3 receptor antagonist reported at ACS

Sep. 6, 1996

No Comments

Potential new treatment for Alzheimer's disease disclosed by SIBIA Neurosciences

Sep. 6, 1996

No Comments

Reversible MAO inhibitors from Hoechst Marion Roussel

Sep. 6, 1996

No Comments

A new CETP inhibitor from Schering-Plough

Sep. 6, 1996

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Conferences
RSS

Roche and Genentech prepare prodrugs of fibrinogen antagonist

Thalidomide derivatives as leads for septic shock therapy

Arginine analogues for shock

CGS-28106 for hypertension and congestive heart failure

Zambon selects a dopaminergic compound for evaluation in cardiovascular/renal disorders

Orally active dual NK1/NK2 antagonist from Merck & Co.

New adenosine A3 receptor antagonist reported at ACS

Potential new treatment for Alzheimer's disease disclosed by SIBIA Neurosciences

Reversible MAO inhibitors from Hoechst Marion Roussel

A new CETP inhibitor from Schering-Plough

Today's news in brief

Today's news in brief

Zelira’s stock triples as cannabinoid outperforms Lyrica in pain

Reprocell reports mixed results for phase II Stemchymal trial in spinocerebellar ataxia

Citing US constitutional violations, Merck the first to challenge the IRA

Conferences RSS

Conferences
RSS